Edwards Lifesciences Corp (NYSE:EW) — Stock Price

$92.03 USD
▲ 2.57% today

Edwards Lifesciences Corp (NYSE:EW) is currently trading at $92.03 USD, up 2.57% today. Over the past 52 weeks, shares have ranged between $72.65 and $95.18. This page tracks Edwards Lifesciences Corp's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see EW market cap overview.

Edwards Lifesciences Corp (EW) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Edwards Lifesciences Corp's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Edwards Lifesciences Corp Income Statement — Revenue, Profit & Earnings by Year

Edwards Lifesciences Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue $6.07 Billion $5.44 Billion $6.00 Billion $5.38 Billion $5.23 Billion
Cost of Revenue $1.33 Billion $1.12 Billion $1.38 Billion $1.17 Billion $1.23 Billion
Gross Profit $4.74 Billion $4.32 Billion $4.62 Billion $4.22 Billion $4.01 Billion
Research & Development $1.08 Billion $1.05 Billion $1.07 Billion $945.20 Million $903.10 Million
SG&A $2.09 Billion $1.79 Billion $1.76 Billion $1.57 Billion $1.49 Billion
Total Operating Expenses $3.10 Billion $2.94 Billion $2.90 Billion $2.51 Billion $2.40 Billion
Operating Income $1.64 Billion $1.38 Billion $1.53 Billion $1.70 Billion $1.61 Billion
EBITDA $1.43 Billion $1.72 Billion $1.53 Billion $1.96 Billion $1.89 Billion
EBIT $1.27 Billion $1.57 Billion $1.53 Billion $1.79 Billion $1.73 Billion
Interest Expense $20.40 Million $19.80 Million $17.60 Million $26.20 Million $24.80 Million
Income Before Tax $1.27 Billion $1.55 Billion $1.60 Billion $1.77 Billion $1.70 Billion
Income Tax Expense $216.90 Million $152.10 Million $198.70 Million $245.50 Million $198.90 Million
Net Income $1.07 Billion $4.17 Billion $1.40 Billion $1.52 Billion $1.50 Billion

Edwards Lifesciences Corp Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Edwards Lifesciences Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets $13.70 Billion $13.06 Billion $9.36 Billion $8.29 Billion $8.50 Billion
Total Current Assets $6.74 Billion $6.29 Billion $4.04 Billion $3.10 Billion $3.18 Billion
Cash & Equivalents $2.94 Billion $3.05 Billion $1.14 Billion $769.00 Million $862.80 Million
Short-term Investments $1.29 Billion $930.70 Million $500.50 Million $446.30 Million $604.00 Million
Net Receivables $912.10 Million $727.40 Million $828.10 Million $699.10 Million $664.90 Million
Inventory $1.13 Billion $1.09 Billion $903.50 Million $875.50 Million $726.70 Million
Property, Plant & Equipment $1.91 Billion $1.78 Billion $1.84 Billion $1.73 Billion $1.64 Billion
Goodwill $1.77 Billion $1.78 Billion $1.15 Billion $1.16 Billion $1.17 Billion
Total Liabilities $3.36 Billion $2.99 Billion $2.64 Billion $2.49 Billion $2.67 Billion
Total Current Liabilities $1.81 Billion $1.51 Billion $1.20 Billion $1.02 Billion $1.03 Billion
Long-term Debt $598.30 Million $597.70 Million $597.00 Million $596.30 Million $595.70 Million
Net Debt $-2.23 Billion $-2.35 Billion $-447.20 Million $-77.70 Million $-172.50 Million
Total Stockholder Equity $10.34 Billion $10.00 Billion $6.65 Billion $5.81 Billion $5.84 Billion
Retained Earnings $14.24 Billion $13.17 Billion $8.99 Billion $7.59 Billion $6.07 Billion

Edwards Lifesciences Corp Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Edwards Lifesciences Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow $1.60 Billion $542.30 Million $895.80 Million $1.22 Billion $1.73 Billion
Capital Expenditures $260.20 Million $252.40 Million $266.30 Million $264.80 Million $329.80 Million
Free Cash Flow $1.33 Billion $289.90 Million $629.50 Million $953.40 Million $1.40 Billion
Investing Cash Flow $-712.90 Million $2.31 Billion $173.80 Million $252.30 Million $-1.72 Billion
Financing Cash Flow $-956.80 Million $-983.00 Million $-711.00 Million $-1.58 Billion $-356.30 Million
Dividends Paid — — $169.90 Million $146.40 Million $158.60 Million
Stock-Based Compensation $158.10 Million $162.30 Million $139.40 Million $126.80 Million $109.30 Million
Depreciation $156.60 Million $155.20 Million $144.90 Million $139.60 Million $134.80 Million
Change in Cash $-119.30 Million $1.91 Billion $375.40 Million $-94.80 Million $-332.80 Million

Edwards Lifesciences Corp Earnings History — EPS Actual vs. Analyst Estimates

Track Edwards Lifesciences Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 23, 2026 — 0.74 —
Apr 23, 2026 0.78 0.73 +6.85%
Feb 10, 2026 0.58 0.62 -6.39%
Oct 30, 2025 0.67 0.59 +13.56%
Jul 24, 2025 0.67 0.62 +8.06%
Apr 23, 2025 0.64 0.60 +6.67%
Feb 04, 2025 0.59 0.55 +6.38%
Oct 24, 2024 0.67 0.59 +13.56%